Anticancer research · 2015
Effect of Race and Insurance on the Outcome of Stage I Non-small Cell Lung Cancer.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Biswas Tithi, Walker Paul, Podder Tarun, Efird Jimmy T
Аннотация
BACKGROUND: Lung cancer is the leading cause of death in the United States, with reported inferior survival among African-Americans.
PATIENTS AND METHODS: Kaplan-Meier and Cox regression methods were used to compare survival outcomes of 569 patients diagnosed with stage I non-small cell lung cancer from 2001-2010.
RESULTS: African-Americans and Whites differed significantly by age, sex, and insurance type. The median follow-up was 2.3 years. The 2-, 5- and 8-year overall survival was 72%, 47%, and 38%, respectively. Age, stage, insurance type, and surgery were significant predictors of overall survival which remained significant after adjusting for other variables, including race, gender, histology, smoking history, treatment era, chemotherapy or radiotherapy which were not.
CONCLUSION: Insurance status but not race is an important predictor of survival in patients with stage I non-small cell lung cancer.
PATIENTS AND METHODS: Kaplan-Meier and Cox regression methods were used to compare survival outcomes of 569 patients diagnosed with stage I non-small cell lung cancer from 2001-2010.
RESULTS: African-Americans and Whites differed significantly by age, sex, and insurance type. The median follow-up was 2.3 years. The 2-, 5- and 8-year overall survival was 72%, 47%, and 38%, respectively. Age, stage, insurance type, and surgery were significant predictors of overall survival which remained significant after adjusting for other variables, including race, gender, histology, smoking history, treatment era, chemotherapy or radiotherapy which were not.
CONCLUSION: Insurance status but not race is an important predictor of survival in patients with stage I non-small cell lung cancer.